Vaxcyte

IPO

Homepage

Vaxcyte was founded in 2013, is headquartered in San Carlos, United States, lists 501–1000 employees, and has 4 recorded funding rounds.

Headquarters
San Carlos
Employees
501–1000
Founded
2013
Business Model
B2B
Last Round
Series DMar 2020
Rounds
4
Type
Public

Indexed holds 4 funding rounds and 11 investors for this company. The full record is or through the API.

About

Vaxcyte is a clinical-stage vaccine innovation company headquartered in San Carlos, California, founded in 2013 by CEO Grant Pickering. The company re-engineers how complex vaccines are made using advanced chemistry and a proprietary cell-free protein synthesis platform to develop difficult-to-manufacture proteins with enhanced immunological benefits. Its pneumococcal conjugate vaccine franchise includes VAX-31 and VAX-24, in Phase 3 and Phase 2 clinical trials respectively, alongside early-stage programs targeting Group A Strep and Shigella.

Summary

Vaxcyte is a Biotech company based in San Carlos, United States, founded in 2013. It lists 501–1000 employees. Its most recent funding was a Series D round in Mar 2020. Investors include Frazier Healthcare, RA Capital Management and Janus Henderson Investors.

Tech & App Stack

4 technologies & apps tracked

Every product and vendor across these categories, with where each signal came from.

Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.

Funding & Exit History

IPOJun 2020

Sign up to see all 5 events

Funding: Series A through Series D. Amounts, valuations, and investors where available.

Investors

Similar Companies

Tiantan Biological / China Biologic (泰邦生物集团)

China's leading blood products manufacturer

Beijing, China1001–5000Biotech, Healthcare
Growth EquityTotal funding$5.1BAug 2022
Pharmaceutical Product Development, Inc. (PPD)Acquired

Global contract research organization providing comprehensive drug development and laboratory ser...

Wilmington, United States10001+Biotech, Healthcare
Private EquityTotal funding$3.9BJan 2019
Warner ChilcottAcquired

Specialty pharmaceutical company

Rockaway, United States1001–5000Biotech, Healthcare
Private EquityTotal funding$3.0BJan 2004
Altos Labs

Altos Labs combines academic science and industry development to create medicines that restore ce...

San Francisco, United States501–1000Life Sciences, Biotech
Series ATotal funding$3.0BJan 2022
Syneos HealthAcquired

Integrated biopharmaceutical solutions company

Burlington, United States10001+Biotech, Healthcare
Private EquityTotal funding$3.0BMay 2017
BeiGeneIPO

BeOne Medicines develops transformative oncology medicines through rigorous science, an accelerat...

Cambridge, United States10001+Biotech, Oncology
Corporate RoundTotal funding$2.8BJan 2020

Your company? Embed this profile

Add the live badge to your site — it stays current as your funding data updates.

Vaxcyte on Indexed.vc
<a href="https://indexed.vc/companies/vaxcyte"><img src="https://indexed.vc/api/badge/company/vaxcyte" alt="Vaxcyte on Indexed.vc" width="260" height="76" /></a>